(Q34645985)

English

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Stephen P Hunger

3

object named as

Stephen P Hunger

1 reference

Europe PubMed Central

3 August 2017

12

object named as

Nita L Seibel

1 reference

Europe PubMed Central

3 August 2017

4

object named as

Nyla A Heerema

1 reference

Europe PubMed Central

3 August 2017

5

object named as

Paul S Gaynon

1 reference

Europe PubMed Central

3 August 2017

author name string

James B Nachman

1

1 reference

Europe PubMed Central

3 August 2017

Mei K La

2

1 reference

Europe PubMed Central

3 August 2017

Caroline Hastings

6

1 reference

Europe PubMed Central

3 August 2017

Leonard A Mattano

7

1 reference

Europe PubMed Central

3 August 2017

Harland Sather

8

1 reference

Europe PubMed Central

3 August 2017

Meenakshi Devidas

9

1 reference

Europe PubMed Central

3 August 2017

David R Freyer

10

1 reference

Europe PubMed Central

3 August 2017

Peter G Steinherz

11

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

5 October 2009

1 reference

Europe PubMed Central

3 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

3 August 2017

27

1 reference

Europe PubMed Central

3 August 2017

31

1 reference

Europe PubMed Central

3 August 2017

5189-5194

1 reference

Europe PubMed Central

3 August 2017

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053149

7 July 2018

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053149

7 July 2018

Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053149

7 July 2018

Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053149

7 July 2018

Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053149

7 July 2018

Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053149

26 October 2018

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053149

26 October 2018

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053149

26 October 2018

Presenting features and treatment outcome of adolescents with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053149

26 October 2018

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19805689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19805689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19805689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/19805689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols

1 reference

https://pubmed.ncbi.nlm.nih.gov/19805689

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2008.20.8959

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34645985&oldid=1618958526"